Objective breast symmetry analysis with the breast analyzing tool (BAT): improved tool for clinical trials

被引:23
|
作者
Krois, Wilfried [1 ]
Romar, Alexander Ken [1 ]
Wild, Thomas [1 ]
Dubsky, Peter [3 ]
Exner, Ruth [1 ,2 ]
Panhofer, Peter [1 ]
Jakesz, Raimund [1 ]
Gnant, Michael [1 ,2 ]
Fitzal, Florian [1 ,2 ]
机构
[1] Med Univ Vienna, Dept Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria
[2] Canc Comprehens Ctr Vienna, Breast Hlth Ctr, Spitalgasse 23, Vienna, Austria
[3] St Anna Brustzentrum, Hirslanden Klin, St Anna Str 32, CH-6006 Luzern, Switzerland
关键词
Breast symmetry; Objective breast analysis; Breast cosmetics; Breast analyzing tool; CANCER CONSERVATIVE TREATMENT; AESTHETIC EVALUATION;
D O I
10.1007/s10549-017-4255-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective cosmetic analysis is important to evaluate the cosmetic outcome after breast surgery or breast radiotherapy. For this purpose, we aimed to improve our recently developed objective scoring software, the Breast Analyzing Tool (BAT(A (R))). A questionnaire about important factors for breast symmetry was handed out to ten experts (surgeons) and eight non-experts (students). Using these factors, the first-generation BAT(A (R)) software formula has been modified and the breast symmetry index (BSI) from 129 women after breast surgery has been calculated by the first author with this new BAT(A (R)) formula. The resulting BSI values of these 129 breast cancer patients were then correlated with subjective symmetry scores from the 18 observers using the Harris scale. The BSI of ten images was also calculated from five observers different from the first author to calculate inter-rater reliability. In a second phase, the new BAT(A (R)) formula was validated and correlated with subjective scores of additional 50 women after breast surgery. The inter-rater reliability analysis of the objective evaluation by the BAT(A (R)) from five individuals showed an ICC of 0.992 with almost no difference between different observers. All subjective scores of 50 patients correlated with the modified BSI score with a high Pearson correlation coefficient of 0.909 (p < .001) which was better compared to the old software (r = 0.769; p < .001). The modified BAT(A (R)) software improves the correlation between subjective and objective BSI values, and may be a new standard for trials evaluating breast symmetry.
引用
收藏
页码:421 / 427
页数:7
相关论文
共 50 条
  • [41] Volpara™ as a measurement tool for breast volume
    Teo, Isabel
    Whelehan, Patsy
    Macaskill, Jane E.
    Vinnicombe, Sarah
    Munnoch, David A.
    Evans, Andrew
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2016, 69 (04): : 581 - 582
  • [42] Cytokines as prognstic tool in breast carcinoma
    Lv, Mingli
    Zhang, Xiaoping
    Cai, Haidong
    Li, Dang
    Wang, Jian
    Fu, Xingjian
    Yu, Fei
    Sun, Ming
    Lv, Zhongwei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 2515 - 2526
  • [43] Requirements Analysis Tool: A Tool for Automatically Analyzing Software Requirements Documents
    Verma, Kunal
    Kass, Alex
    SEMANTIC WEB - ISWC 2008, 2008, 5318 : 751 - 763
  • [44] BREAST PROGRAM CARE MANAGEMENT TOOL
    Leighliter, Marjorie
    ONCOLOGY NURSING FORUM, 2022, 49 (02) : E31 - E32
  • [45] Contribution of clinical trials to improved clinical outcomes for patients with metastatic breast cancer (MBC).
    Lee, Ji Yun
    Lim, Sung Hee
    Lee, Min-Young
    Kim, Haesu
    Ahn, Jin Seok
    Im, Young-Hyuck
    Park, Yeon Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] Neoadjuvant Trials in ER+ Breast Cancer: A Tool for Acceleration of Drug Development and Discovery
    Guerrero-Zotano, Angel L.
    Arteaga, Carlos L.
    CANCER DISCOVERY, 2017, 7 (06) : 561 - 574
  • [47] Potential of using breast milk as a tool to study breast cancer and breast cancer risk
    Arcaro, Kathleen F.
    Anderton, Douglas L.
    FUTURE ONCOLOGY, 2008, 4 (05) : 595 - 597
  • [48] Improved statistical analysis tool
    Anon
    1600, National Institute of Standards and Technology (106):
  • [49] Molecular characterization of breast cell lines: a tool for breast cancer studies
    E Charafe-Jauffret
    C Ginestier
    F Monville
    J Adélaïde
    P Finetti
    F Bertucci
    L Xerri
    J Jacquemier
    D Birnbaum
    Breast Cancer Research, 7
  • [50] Molecular Breast Imaging as a Cost Effective Diagnostic Tool for Breast Cancer
    Larsen, A. R.
    Hughes, J. H.
    Frazier, T. G.
    CANCER RESEARCH, 2009, 69 (24) : 768S - 769S